Showing results (281-290 of 554) with videos related to
Sort By:
Pageof 56
Clinical Genitourinary Cancer|May 13, 2021
Q-TWiST Analysis of Tivozanib Versus Sorafenib in Patients With Advanced Renal Cell Carcinoma in the TIVO-3 StudyMichael Szarek, Michael N Needle, Brian I Rini, et al.The Oncologist|February 6, 2025
Updated overall survival in patients with prior checkpoint inhibitor therapy in the phase III TIVO-3 studyMiguel Zugman, David F McDermott, Bernard J Escudier, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
Phase III trial of carboplatin and paclitaxel with or without sorafenib in metastatic melanomaKeith T Flaherty, Sandra J Lee, Fengmin Zhao, et al.Cancer Medicine|October 11, 2017
High frequency of brain metastases after adjuvant therapy for high-risk melanomaWolfram E Samlowski, James Moon, Merle Witter, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin 2, and interferon alpha-2B in patients with metastatic melanomaD F McDermott, J W Mier, D P Lawrence, et al.Cell|April 10, 2007
The mammalian Golgi regulates numb signaling in asymmetric cell division by releasing ACBD3 during mitosisYan Zhou, Joshua B Atkins, Santiago B Rompani, et al.Frontiers in Oncology|January 31, 2022
Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint TherapyAidan M Burke, Michael Carrasquilla, Walter C Jean, et al.Blood|November 15, 1990
Inhibition of interleukin-2-induced tumor necrosis factor release by dexamethasone: prevention of an acquired neutrophil chemotaxis defect and differential suppression of interleukin-2-associated side effectsJ W Mier, G Vachino, M S Klempner, et al.Cancer|October 7, 2015
Cardiovascular toxicity after antiangiogenic therapy in persons older than 65 years with advanced renal cell carcinomaSekwon Jang, Chaoyi Zheng, Huei-Ting Tsai, et al.Internal Medicine Journal|December 9, 2014
Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014C C Blyth, N M Gilroy, S D Guy, et al.Pageof 56